3-beta-D-ribofuranosylthiazolo[4,5-d]pyr idimine nucleosides and uses thereof

Details for Australian Patent Application No. 2004320625 (hide)

Owner Anadys Pharmaceuticals, Inc.

Inventors Clark, David Louis; Lennox, Joseph, R.; Xiang, Alan, X.; Averett, Devron, R.; Webber, Stephen, E.; Rueden, Erik J.

Agent Davies Collison Cave

Pub. Number AU-B-2004320625

PCT Pub. Number WO2005/121162

Filing date 7 June 2004

Wipo publication date 22 December 2005

Acceptance publication date 27 August 2009

International Classifications

C07H 19/24 (2006.01) Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical

A61K 31/7052 (2006.01)

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

Event Publications

7 December 2006 PCT application entered the National Phase

  PCT publication WO2005/121162 Priority application(s): WO2005/121162

27 August 2009 Application Accepted

  Published as AU-B-2004320625

25 March 2010 Amendment Made

  The nature of the amendment is: Amend the invention title to read 3-beta-D-ribofuranosylthiazolo[4,5-d]pyrimidine nucleosides and uses thereof 2005

1 April 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004320632-Method and apparatus for forming a heat exchanger

2004320622-Chimeric gapped oligomeric compositions